EMCURE2024-10-012024-12-31 EMCURE2024-10-012024-12-31 EMCURE2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member EMCURE2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member EMCURE2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member EMCURE2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member EMCURE2024-12-31 EMCURE2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member EMCURE2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member EMCURE2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member EMCURE2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544210 EMCURE NOTLISTED Emcure Pharmaceuticals Limited Equity 2024-04-01 2025-03-31 2025-02-06 2025-01-24 INR Millions Third quarter 14:00:00 14:45:00 2025-02-06 2025-02-06 Not applicable Single segment PHARMACEUTICALS 2024-10-01 2024-12-31 Unaudited Consolidated 19626300000.00 38960000.00 19665260000.00 3998250000.00 4289340000.00 -460320000.00 3669330000.00 317780000.00 968060000.00 4583630000.00 17366070000.00 2299190000.00 0.00 2299190000.00 589310000.00 148970000.00 738280000.00 0.00 1560910000.00 0.00 0.00 0.00 0.00 1560910000.00 -582970000.00 977940000.00 1537220000.00 23690000.00 954250000.00 23690000.00 1894320000.00 10 8.12 8.12 0.00 0.00 8.12 8.12 For detailed notes refer full results uploaded on website of stock exchanges and company. Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 57797520000.00 628080000.00 58425600000.00 11230280000.00 13113790000.00 -1799140000.00 10729270000.00 1367590000.00 2872910000.00 13803540000.00 51318240000.00 7107360000.00 0.00 7107360000.00 2006040000.00 -980000.00 2005060000.00 0.00 5102300000.00 0.00 0.00 0.00 0.00 5102300000.00 30670000.00 5132970000.00 4923750000.00 178550000.00 4954560000.00 178410000.00 1894320000.00 10 26.44 26.44 0.00 0.00 26.44 26.44 Net (gain) / loss on foreign currency transactions 71350000.00 Other Expenses 4512280000.00 Net (gain) / loss on foreign currency transactions 69520000.00 Other Expenses 13734020000.00 Other comprehensive income/(loss) not to be be reclassified to profit or loss -2100000.00 Other comprehensive income/(loss) not to be be reclassified to profit or loss -7160000.00 -2100000.00 -7160000.00 -1000000.00 -2010000.00 Other comprehensive income/(loss) to be be reclassified to profit or loss -581870000.00 Other comprehensive income/(loss) to be be reclassified to profit or loss 35820000.00 -581870000.00 35820000.00 0.00 0.00